Saturday , October 23 2021

USFDA concludes inspection at Cadila Healthcare’s manufacturing facility in Ahmedabad

United States Food and Drug Administration (USFDA) has concluded inspection at Cadila Healthcare’s manufacturing facility located at Pharmez in Ahmedabad with one observation. The inspection was conducted from March 25, 2019 to April 02, 2019. The inspection includes product specific pre-approval and post approval inspections and a GMP inspection.

Cadila Healthcare is an India-based pharmaceutical company. The company’s subsidiaries include Zydus Wellness, Liva Pharmaceuticals, Biochem Pharmaceutical Industries, Zydus Technologies, German Remedies, Dialforhealth India, Dialforhealth Unity and Dialforhealth Greencross, among others.

Please share this news
<div id="taboola-below-article-thumbnails"></div>
<script type="text/javascript">
  window._taboola = window._taboola || [];
    mode: 'thumbnails-a',
    container: 'taboola-below-article-thumbnails',
    placement: 'Below Article Thumbnails',
    target_type: 'mix'